News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
MEDecision Sets IPO At 5.5 Million Shares For $14-$16
November 1, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Oct 31 (Reuters) - MEDecision Inc., which provides software and clinical content to healthcare payers, on Tuesday set its planned initial public offering at 5.5 million shares for between $14 and $16 per share.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Obesity
Is Metsera Worth The Fuss?
November 5, 2025
·
4 min read
·
Annalee Armstrong
Earnings
Novo Execs Face Skeptical Analysts Amid Metsera Buyout Drama
November 5, 2025
·
5 min read
·
Annalee Armstrong
Earnings
Pfizer Fields Novo’s $10B Curveball, With Bourla Promising To Fight for Metsera
November 4, 2025
·
5 min read
·
Annalee Armstrong
Mergers & acquisitions
Novo Ups Ante In Metsera Buyout Drama With $10B Offer, Beating Pfizer’s New Bid
November 4, 2025
·
1 min read
·
Annalee Armstrong